Loading...
Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination
PURPOSE: The purpose of this review is to summarize and discuss the recently published data (both original studies and reviews) on the oral medication NEPA, consisting of netupitant (a neurokinin-1 receptor antagonist [NK1RA], 300 mg dose) and palonosetron (5-hydroxytryptamine [serotonin or 5HT] typ...
Saved in:
| Published in: | Ther Clin Risk Manag |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4859423/ https://ncbi.nlm.nih.gov/pubmed/27194913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S81126 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|